Navigation Links
WuXi PharmaTech Selected as One of the Top Ten Employer for New College Graduates in Pharmaceutical Industry in 2009
Date:8/14/2009

SHANGHAI, Aug. 14 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology, and medical device research and development outsourcing company, with operations in China and the United States, today announced that it had been selected as one of the top ten employers in the pharmaceutical industry in China in an online survey of new college graduates by China HR, a leading recruitment website in China. WuXi PharmaTech was the only contract research organization winning this award.

(Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO )

The survey captures the views of 210,000 Chinese students and covers approximately 630 universities and 3,800 businesses. The winning companies were selected on the basis of career development opportunities, enterprise capabilities, culture, and salary and benefits. Now in its sixth year, the survey has become the authoritative source of the opinions of new college graduates in China.

"College students in China have enormous potential, and it is essential that the best Chinese companies tap their talent," said Bob Zhu, Vice President of Human Resources and Corporate Communications. "At WuXi PharmaTech, our people are our most valuable asset and the source of our innovation. We strive to provide the college graduates that we hire with fulfilling careers in one of the world's most dynamic and important industries-pharmaceutical research and development."

WuXi PharmaTech has one of the best-educated and best-trained work forces in China. The company provides extensive training to our more than 4,000 employees, both in specific job skills and in more general areas, such as the English language and business management. The WuXi PharmaTech Science Seminar series invites the world's top scientific minds and leaders in the pharmaceutical industry to speak to our company's scientists, thereby enriching their work experience and enhancing their scientific knowledge.

    For more information, please contact:

    WuXi PharmaTech (Cayman) Inc.
     Ronald Aldridge (for investors)
     Director of Investor Relations
     Tel:   +1-201-585-2048
     Email: ir@wuxiapptec.com

     Stephanie Liu (for the media)
     Tel:   +86-21-5046-4362
     Email: pr@wuxiapptec.com

'/>"/>
SOURCE WuXi PharmaTech (Cayman) Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. WuXi PharmaTech Appoints Dr. Chi-Chung Chan as Vice President of Pharmacology
2. WuXi PharmaTech Files 2008 Annual Report on Form 20-F
3. WuXi PharmaTech Announces First-Quarter 2009 Results
4. WuXi PharmaTech Appoints Hao Zhou as Vice President of Finance
5. Pharmatech Oncology Launches New Data Management Business Unit
6. WuXi PharmaTech Schedules Fourth Quarter 2008 Earnings Release on Thursday, March 26, 2009
7. WuXi PharmaTech Announces CFO Benson Tsang to Leave Company; COO Edward Hu Named Acting CFO
8. WuXi PharmaTech Honored on the Deloitte Technology Fast 500 Asia Pacific 2008 List for the Fifth Consecutive Year
9. WuXi PharmaTech Appoints Stewart Hen and Ning Zhao to Its Board of Directors; Tao Lin Leaves Board
10. WuXi PharmaTech to Present at 20th Annual Piper Jaffray Healthcare Conference
11. WuXi PharmaTech Expands Collaboration for Fully Integrated Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... New York, NY (PRWEB) , ... October 13, 2017 , ... ... most influential people in business to advocate for action towards gender equality at their ... 18,000 views from around the globe, and reached a social audience of over 3 ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the Mountains to the Mission ... lost souls in the Philippines. “The Journey: From the Mountains to the Mission Field” ... the Bible. She has taught all ages and currently teaches a class of ladies ...
(Date:10/12/2017)... WAUSAU, Wis. (PRWEB) , ... October 12, 2017 ... ... formulated standard products to meet the demand of today’s consumer and regulatory authorities ... team of probiotic experts and tested to meet the highest standard. , ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. Parsa Mohebi, ... a medical article to the newly revamped Cosmetic Town journal section, ... hair transplant procedure known as Follicular Unit Extraction (FUE). , Dr. ...
(Date:10/12/2017)... ... ... Health Literacy Innovations (HLI), creator of the Health Literacy ... Patient Education Network (CPEN), an independent professional organization that shares best practices in ... , As CPEN’s strategic partner, HLI will help support CPEN members by sharing ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, Inc. ... response letter from the U.S. Food and Drug Administration ... of sirukumab for the treatment of moderately to severely ... additional clinical data are needed to further evaluate the ... severely active RA. ...
(Date:9/19/2017)... Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses ... today:   ... Jim ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D and business ...
(Date:9/18/2017)... 2017 EpiVax, Inc. ("EpiVax") a ... immune engineering, today announced a new NIH-funded ... ... and presents a challenge for traditional flu ... be effective. Using state-of-the-art bioinformatics and molecular modeling methods, ...
Breaking Medicine Technology: